16.51
0.30 (1.85%)
0.30 (1.85%)
Upgrade to Real-Time
Afterhours (Closed)
Low
9.01
High
21.30
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aerie Pharmaceuticals Inc | AERI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.30 | 1.85% | 16.51 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.02 | 15.83 | 16.57 | 16.51 | 16.21 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 15.00 | 16.58 | 1.58 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,971 | 1,089,183 | $ 16.06 | $ 17,490,704 | 487,896 | 9.01 - 21.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:02:40 | 2 | $ 16.58 | USD |
Aerie Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 774.21M | 46.89M | 45.81M | $ 83.14M | $ - | -3.98 | -4.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 2.40% |
Aerie Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AERI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.65 | 16.57 | 15.34 | 15.85 | 469,485 | 0.86 | 5.5% |
| 1 Month | 18.10 | 18.54 | 14.91 | 16.11 | 491,019 | -1.59 | -8.78% |
| 3 Months | 18.40 | 19.42 | 14.91 | 17.12 | 477,006 | -1.89 | -10.27% |
| 6 Months | 12.89 | 21.30 | 12.67 | 17.10 | 599,497 | 3.62 | 28.08% |
| 1 Year | 14.82 | 21.30 | 9.01 | 14.35 | 647,218 | 1.69 | 11.4% |
| 3 Years | 63.75 | 74.75 | 9.01 | 25.00 | 746,235 | -47.24 | -74.1% |
| 5 Years | 18.31 | 74.75 | 9.01 | 31.40 | 659,070 | -1.80 | -9.83% |
Aerie Pharmaceuticals Description
| Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases. Its main products are Rhopressa and Roclatan. The company mainly operates in North America. |
